Other studies found a conflicting trend i.e. attenuated CPT1a levels in the NAFLD/sedentary but increased in the NAFLD/exercise groups (Evangelista et al., 2015[35]; Ok et al., 2018[111]; Pereira et al., 2019[117]). Here, CPT1A is linked to metabolic dysfunction-associated steatotic liver disease.